Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial.

Fonseca VA, Lavery LA, Thethi TK, Daoud Y, DeSouza C, Ovalle F, Denham DS, Bottiglieri T, Sheehan P, Rosenstock J.

Am J Med. 2013 Feb;126(2):141-9. doi: 10.1016/j.amjmed.2012.06.022. Epub 2012 Dec 5.

PMID:
23218892
2.

Nutritional management of patients with diabetic peripheral neuropathy with L-methylfolate-methylcobalamin-pyridoxal-5-phosphate: results of a real-world patient experience trial.

Trippe BS, Barrentine LW, Curole MV, Tipa E.

Curr Med Res Opin. 2016;32(2):219-27. doi: 10.1185/03007995.2015.1103215. Epub 2015 Dec 8.

PMID:
26439233
3.

Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.

Vinik AI, Bril V, Kempler P, Litchy WJ, Tesfaye S, Price KL, Bastyr EJ 3rd; MBBQ Study Group.

Clin Ther. 2005 Aug;27(8):1164-80.

PMID:
16199243
5.

Metanx alleviates multiple manifestations of peripheral neuropathy and increases intraepidermal nerve fiber density in Zucker diabetic fatty rats.

Shevalye H, Watcho P, Stavniichuk R, Dyukova E, Lupachyk S, Obrosova IG.

Diabetes. 2012 Aug;61(8):2126-33. doi: 10.2337/db11-1524. Epub 2012 Jun 29.

8.
9.

Effects of acetyl-L-carnitine and methylcobalamin for diabetic peripheral neuropathy: A multicenter, randomized, double-blind, controlled trial.

Li S, Chen X, Li Q, Du J, Liu Z, Peng Y, Xu M, Li Q, Lei M, Wang C, Zheng S, Zhang X, Yu H, Shi J, Tao S, Feng P, Tian H.

J Diabetes Investig. 2016 Sep;7(5):777-85. doi: 10.1111/jdi.12493. Epub 2016 Mar 28.

10.

A medicinal food provides food for thought in managing diabetic neuropathy.

Vinik AI.

Am J Med. 2013 Feb;126(2):95-6. doi: 10.1016/j.amjmed.2012.08.008. No abstract available.

PMID:
23331432
11.

A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report.

Valensi P, Le Devehat C, Richard JL, Farez C, Khodabandehlou T, Rosenbloom RA, LeFante C.

J Diabetes Complications. 2005 Sep-Oct;19(5):247-53.

PMID:
16112498
13.
14.

Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study.

Rauck RL, Shaibani A, Biton V, Simpson J, Koch B.

Clin J Pain. 2007 Feb;23(2):150-8.

PMID:
17237664
15.
16.

Metanx and early stages of diabetic retinopathy.

Liu H, Tang J, Lee CA, Kern TS.

Invest Ophthalmol Vis Sci. 2015 Jan 8;56(1):647-53. doi: 10.1167/iovs.14-15220.

17.

The effect of oral prostaglandin analogue on painful diabetic neuropathy: a double-blind, randomized, controlled trial.

Shin S, Kim KJ, Chang HJ, Lee BW, Yang WI, Cha BS, Choi D.

Diabetes Obes Metab. 2013 Feb;15(2):185-8. doi: 10.1111/dom.12010. Epub 2012 Sep 30.

PMID:
22974254
18.
19.

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

Clin Ther. 2008 Aug;30(8):1448-60. doi: 10.1016/j.clinthera.2008.08.006. Erratum in: Clin Ther. 2008 Oct;30(10):1937.

PMID:
18803987
20.

A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people.

Kwok T, Lee J, Law CB, Pan PC, Yung CY, Choi KC, Lam LC.

Clin Nutr. 2011 Jun;30(3):297-302. doi: 10.1016/j.clnu.2010.12.004. Epub 2011 Jan 8.

PMID:
21216507

Supplemental Content

Support Center